AnaptysBio Inc Stock
AnaptysBio Inc Stock
A very strong showing by AnaptysBio Inc today, with an increase of €1.96 (4.310%) compared to yesterday's price.
The stock is an absolute favorite of our community with 24 Buy predictions and no Sell predictions.
With a target price of 60 € there is a positive potential of 26.37% for AnaptysBio Inc compared to the current price of 47.48 €.
So far the community has only identified positive things for AnaptysBio Inc stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of AnaptysBio Inc in the next few years
Pros
?
S********** s********
?
B****
?
C******** o* t** e**********
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of AnaptysBio Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| AnaptysBio Inc | 4.310% | -1.939% | -20.112% | 103.214% | 5.860% | 195.584% | 127.600% |
| NanoViricides Inc. | 1.520% | -1.493% | 10.000% | -8.333% | 41.935% | -3.650% | -61.062% |
| Ocuphire Pharma Inc. | 1.800% | 30.469% | -6.180% | 246.833% | 98.573% | -8.242% | -6.180% |
| Actinium Pharmaceuticals Inc. | 2.040% | -8.156% | -15.278% | -46.057% | -39.354% | -88.472% | -86.929% |
Comments
AnaptysBio (ANAB) had its "buy" rating reaffirmed by HC Wainwright. They now have a $95.00 price target on the stock.
Show more
Ratings data for ANAB provided by MarketBeat
AnaptysBio (ANAB) had its "buy" rating reaffirmed by UBS Group AG.
Show more
Ratings data for ANAB provided by MarketBeat
AnaptysBio (ANAB) was given a new $85.00 price target by Leerink Partners. They now have an "outperform" rating on the stock.
Show more
Ratings data for ANAB provided by MarketBeat